SAN FRANCISCO — The sumatriptan 3-mg subcutaneous auto-injector (Zembrace SymTouch, Promius Pharma) approved by the US Food and Drug Administration (FDA) for acute treatment of episodic migraine, with ...
Please provide your email address to receive an email when new articles are posted on . A low dose of sumatriptan provided significantly higher 2-hour pain freedom and 2-hour pain relief vs. placebo, ...
If sumatriptan isn’t working for your migraine symptoms, consider trying a different form of the medication, such as a nasal spray or injection. These options may be more effective as you absorb them ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results